Approaching the culmination of the story about gene therapy of AIPL1-associated retinal degeneration, one cannot help but mention an open-label, first-in-human interventional study, the results of which were published recently and which directly showed that intervention by gene supplementation therapy was safe and could improve outcomes in children with LCA4. Here, AIPL1 is linked to retinal degeneration.